Search research articles
Contact Us
Filters
Showing results (111-120 of 151) with videos related to
Page
of 16
Sort By:
Annals of Internal Medicine
|
March 6, 1999
Association between the Epworth sleepiness scale and the multiple sleep latency test in a clinical population
S R Benbadis, E Mascha, M C Perry, et al.
IEEE Transactions on Bio-Medical Engineering
|
May 9, 2001
An arrhythmia detector and heart rate estimator for overnight polysomnography studies
A Bartolo, B D Clymer, R C Burgess, et al.
Seminars in Oncology
|
December 1, 1995
Hodgkin's disease: is staging laparotomy still necessary?
H J Murrell, M C Perry, J J Muscato, et al.
Clinical Lung Cancer
|
January 1, 2004
Carboplatin/etoposide/paclitaxel in the treatment of patients with extensive small-cell lung cancer
H B Niell, M C Perry, G Clamon, et al.
Journal of the National Cancer Institute
|
February 17, 1993
Interleukin-2 activity in patients with extensive small-cell lung cancer: a phase II trial of Cancer and Leukemia Group B
G Clamon, J Herndon, M C Perry, et al.
Cancer Treatment Reports
|
February 1, 1979
Phase II study of 5-fluorouracil, methyl-CCNU, and daunorubicin in colorectal cancer: a Cancer and Leukemia Group B study
L A White, M C Perry, C G Kardinal, et al.
Cancer
|
February 15, 1989
Bone marrow involvement in small cell lung cancer. Clinical significance and correlation with routine laboratory variables
D B Tritz, D C Doll, Q S Ringenberg, et al.
Scientific Reports
|
May 24, 2020
The impact of cervical cytobrush sampling on cervico-vaginal immune parameters and microbiota relevant to HIV susceptibility
A Mohammadi, S Bagherichimeh, M C Perry, et al.
International Journal of Sports Medicine
|
September 15, 2005
Number of repetitions to maximum in hop tests in patients with anterior cruciate ligament injury
M C Perry, M C Morrissey, J S Jones, et al.
American Journal of Clinical Oncology
|
October 1, 1992
Intensive etoposide and carboplatin chemotherapy for advanced non-small-cell lung cancer. A phase II trial of the Cancer and Leukemia Group B
A P Lyss, M C Perry, M Goutsou, et al.
Page
of 16
Search research articles
Search
Showing results (111-120 of 151) with videos related to
Sort By:
Page
of 16
Annals of Internal Medicine
|
March 6, 1999
Association between the Epworth sleepiness scale and the multiple sleep latency test in a clinical population
S R Benbadis, E Mascha, M C Perry, et al.
IEEE Transactions on Bio-Medical Engineering
|
May 9, 2001
An arrhythmia detector and heart rate estimator for overnight polysomnography studies
A Bartolo, B D Clymer, R C Burgess, et al.
Seminars in Oncology
|
December 1, 1995
Hodgkin's disease: is staging laparotomy still necessary?
H J Murrell, M C Perry, J J Muscato, et al.
Clinical Lung Cancer
|
January 1, 2004
Carboplatin/etoposide/paclitaxel in the treatment of patients with extensive small-cell lung cancer
H B Niell, M C Perry, G Clamon, et al.
Journal of the National Cancer Institute
|
February 17, 1993
Interleukin-2 activity in patients with extensive small-cell lung cancer: a phase II trial of Cancer and Leukemia Group B
G Clamon, J Herndon, M C Perry, et al.
Cancer Treatment Reports
|
February 1, 1979
Phase II study of 5-fluorouracil, methyl-CCNU, and daunorubicin in colorectal cancer: a Cancer and Leukemia Group B study
L A White, M C Perry, C G Kardinal, et al.
Cancer
|
February 15, 1989
Bone marrow involvement in small cell lung cancer. Clinical significance and correlation with routine laboratory variables
D B Tritz, D C Doll, Q S Ringenberg, et al.
Scientific Reports
|
May 24, 2020
The impact of cervical cytobrush sampling on cervico-vaginal immune parameters and microbiota relevant to HIV susceptibility
A Mohammadi, S Bagherichimeh, M C Perry, et al.
International Journal of Sports Medicine
|
September 15, 2005
Number of repetitions to maximum in hop tests in patients with anterior cruciate ligament injury
M C Perry, M C Morrissey, J S Jones, et al.
American Journal of Clinical Oncology
|
October 1, 1992
Intensive etoposide and carboplatin chemotherapy for advanced non-small-cell lung cancer. A phase II trial of the Cancer and Leukemia Group B
A P Lyss, M C Perry, M Goutsou, et al.
Page
of 16